OMEICOS Therapeutics GmbH

OMEICOS Therapeutics GmbH

OMEICOS Therapeutics GmbH

OMEICOS Therapeutics is a biopharmaceutical company developing firstinclass small molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation..
Type
B2c
Founded
2013
Raised
$36.5M
Follow us
Alexa global traffic share
02 Nov 2018
€17,000,000
Venture capital (Series C)
High-Tech Gründerfonds, The Falck Revocable Trust, KFW Group, +5

Omeicos Therapeutics Raises €17M in Series C Financing

FinSMEs
+1
04 Oct 2017
01 Mar 2017
€8,300,000
Venture capital (Series B)
High-Tech Gruenderfonds, The Falck Revocable Trust, Ascenion, +4

Login

CrunchBase
+7
15 Apr 2015
$6,579,017
Venture capital (Series A)
18 Nov 2012
Seed fund